Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Ardent Health Reports Decrease in Net Income for 2025

Ardent Health reported 2025 net income of $230.1 million, down from $299.7 million in 2024, while adjusted EBITDA fell to $447.3 million from $498.5 million a year earlier.

For the fourth quarter, net income was $74.3 million, and adjusted EBITDAR was $175.7 million.

The 2025 adjusted EBITDA total reflected several sizable swings versus 2024: Income tax expense declined to $56.2 million from $63.4 million. Interest expense fell to $55.2 million from $65.6 million. Depreciation and amortization rose to $155.7 million from $146.3 million. Noncontrolling interest earnings increased in magnitude to $94.3 million from $89.4 million. Loss on extinguishment and modification of debt increased to $7.3 million from $3.4 million. Other non-operating losses were $1.1 million, compared with a $4.9 million gain in 2024. Cybersecurity incident recoveries, net were $22.7 million, compared with $21.5 million in 2024. Certain legal matters and related costs were $900,000, down from $2.0 million. Restructuring, exit and acquisition-related costs edged up to $13.3 million from $12.8 million. Epic implementation expenses rose to $4.8 million from $3.2 million. Equity-based compensation more than doubled to $39.3 million from $18.0 million. Loss from disposed operations was $207,000, compared with income of $79,000 in 2024.

Adjusted EBITDAR for 2025 was $611.6 million, up from the year’s adjusted EBITDA because it added back $164.3 million of rent expense payable to REITs. For the fourth quarter alone, rent expense payable to REITs was $41.8 million, including $38.9 million tied to Ventas leases and $2.9 million tied to the MPT lease.

The fourth quarter also included: Net income of $74.3 million Income tax expense of $18.1 million Interest expense of $12.4 million Depreciation and amortization of $41.0 million Noncontrolling interest earnings of $29.3 million Restructuring, exit and acquisition-related costs of $5.3 million Epic expenses of $1.9 million Equity-based compensation of $9.1 million Following these announcements, the company's shares moved 1.39%, and are now trading at a price of $10.91. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS